A professional company in PEG derivatives and pharmaceutical intermediates named Hunan Huateng Pharmaceutical Co., Ltd (hereinafter referred to as Huateng Pharma) recently announced its attendance at the upcoming CPHI China 2023. This three-day event will take place at Shanghai New International Expo Center from 19th-21st June, 2023.
Huateng Pharma is a one-stop contract development and manufacturing organization (CDMO) for pharmaceutical intermediates and PEG derivatives from clinical supply to commercial scale. We have established a 5000 square meters R&D center , equipped with nearly 100 sets of high-end analytical and testing instruments and automatic reaction equipment. We also have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production.
“We are very much looking forward to attending this CPhI China, which will give us the opportunity to learn from the best minds of the chemical world, and we also have the chance to communicate with our customers face-to-face. "said a senior manager at Huateng Pharma. "We look forward to interacting with our customers face to face, sharing updates on our plant's progress and presenting our plant's capacity."
Basic Information about the CPHI China 2023
Date: 19-21 June, 2023
Location: Shanghai New International Expo Center
Booth No.: W1D08
Huateng Pharma, founded in 2013, is a one-stop contract development and manufacturing organization (CDMO) to manufacture and supply researchers with pharmaceutical intermediates, PEG raw materials & PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents.
Pharmaceutical Intermediates: Offer pharma intermediates'process development and scale-up production with capacities varying from gram to kilograms and multi tons.
PEG Deriavtives: Stock of 3000+ high-quality PEG derivatives, monodispersed PEG linkers, multi-arm PEGs from R&D through GMP commercial scale.